{
    "2021-11-22": [
        [
            {
                "time": "",
                "original_text": "CAR-T治疗肿瘤再迎重大进展，电源管理芯片供应紧缺丨明日主题前瞻",
                "features": {
                    "keywords": [
                        "CAR-T",
                        "肿瘤",
                        "重大进展",
                        "电源管理芯片",
                        "供应紧缺"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "半导体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "辅助生殖站上风口，底部放量的低估值股来了",
                "features": {
                    "keywords": [
                        "辅助生殖",
                        "风口",
                        "低估值股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "进博会观察|双轮驱动 复星打造全球化动力新引擎",
                "features": {
                    "keywords": [
                        "进博会",
                        "复星",
                        "双轮驱动",
                        "全球化",
                        "动力新引擎"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "多元化企业集团"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星国际陈启宇：中国企业成为全球创新药研发全链条的重要参与者",
                "features": {
                    "keywords": [
                        "复星国际",
                        "陈启宇",
                        "全球创新药",
                        "研发全链条",
                        "重要参与者"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}